Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Adicet Bio Inc ACET

Healthcare Biotechnology
Adicet Bio, Inc. is a clinical stage biotechnology company. The Company is engaged in advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the... see more

Recent & Breaking News (NDAQ:ACET)

Moore Kuehn Encourages TORC, STML, KLXE, and PTLA Investors to Contact Law Firm

PR Newswire May 5, 2020

Shareholder Investigation: Halper Sadeh LLP Investigates the Following Companies; Investors are Encouraged to Contact the Firm - TORC, STML, KLXE

ACCESSWIRE IA May 4, 2020

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of resTORbio, Inc. - TORC

PR Newswire May 4, 2020

TORC, ETFC, TERP, and WLTW SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers

GlobeNewswire May 4, 2020

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Sale of These Companies; Investors are Encouraged to Contact the Firm - TERP, TORC, STML

ACCESSWIRE IA May 4, 2020

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of resTORbio, Inc.

PR Newswire May 1, 2020

Lifshitz Law Firm, P.C. Announces Investigation of CenterState Bank Corporation (CSFL), resTORbio, Inc. (TORC), Tetraphase Pharmaceuticals, Inc. (TTPH), and The Meet Group, Inc. (MEET)

GlobeNewswire April 30, 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Sale of These Companies; Investors are Encouraged to Contact the Firm - MINI, TORC, ETFC

ACCESSWIRE IA April 30, 2020

resTORbio to Host its 2020 Annual Shareholder Meeting Virtually on June 3, 2020

GlobeNewswire April 30, 2020

RESTORBIO, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger

ACCESSWIRE IA April 29, 2020

resTORbio Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of resTORbio, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm

PR Newswire April 29, 2020

resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology

GlobeNewswire April 29, 2020

resTORbio Announces Delay of its Ongoing Phase 1b/2a trial of RTB101 in Patients with Parkinson's Disease Due to COVID-19 Level 4 Alert in New Zealand

GlobeNewswire April 3, 2020

resTORbio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update

GlobeNewswire March 12, 2020

resTORbio to Present at the 9th Annual Leerink Partners Global Healthcare Conference

GlobeNewswire February 20, 2020

resTORbio Announces Interim Results for Phase 1b/2a Trial of RTB101 in Patients with Parkinson's Disease and Provides Corporate Update

GlobeNewswire February 19, 2020

resTORbio to Present at Upcoming Investor Conferences

GlobeNewswire November 26, 2019

resTORbio Announces That the Phase 3 PROTECTOR 1 Trial of RTB101 in Clinically Symptomatic Respiratory Illness Did Not Meet the Primary Endpoint

GlobeNewswire November 15, 2019

resTORbio Reports Third Quarter 2019 Financial Results and Corporate Update

GlobeNewswire November 5, 2019

AMAG Pharmaceuticals Announces Settlement Agreement with Caligan Partners LP

GlobeNewswire October 8, 2019